Connection
David Arciniegas to Cognition Disorders
This is a "connection" page, showing publications David Arciniegas has written about Cognition Disorders.
|
|
Connection Strength |
|
|
|
|
|
3.812 |
|
|
|
-
Wortzel HS, Arciniegas DB. The DSM-5 approach to the evaluation of traumatic brain injury and its neuropsychiatric sequelae. NeuroRehabilitation. 2014; 34(4):613-23.
Score: 0.341
-
Arciniegas DB. Cholinergic dysfunction and cognitive impairment after traumatic brain injury. Part 2: evidence from basic and clinical investigations. J Head Trauma Rehabil. 2011 Jul-Aug; 26(4):319-23.
Score: 0.287
-
Arciniegas DB. Cholinergic dysfunction and cognitive impairment after traumatic brain injury. Part 1: the structure and function of cerebral cholinergic systems. J Head Trauma Rehabil. 2011 Jan-Feb; 26(1):98-101.
Score: 0.277
-
Oskarsson B, Quan D, Rollins YD, Neville HE, Ringel SP, Arciniegas DB. Using the Frontal Assessment Battery to identify executive function impairments in amyotrophic lateral sclerosis: A preliminary experience. Amyotroph Lateral Scler. 2010; 11(1-2):244-7.
Score: 0.259
-
Anderson CA, Arciniegas DB. Cognitive sequelae of hypoxic-ischemic brain injury: a review. NeuroRehabilitation. 2010; 26(1):47-63.
Score: 0.259
-
Jervis LL, Fickenscher A, Beals J, Cullum CM, Novins DK, Manson SM, Arciniegas DB. Predictors of performance on the MMSE and the DRS-2 among American Indian elders. J Neuropsychiatry Clin Neurosci. 2010; 22(4):417-25.
Score: 0.259
-
Silver JM, McAllister TW, Arciniegas DB. Depression and cognitive complaints following mild traumatic brain injury. Am J Psychiatry. 2009 Jun; 166(6):653-61.
Score: 0.248
-
Silver JM, Koumaras B, Meng X, Potkin SG, Reyes PF, Harvey PD, Katz DI, Gunay I, Arciniegas DB. Long-term effects of rivastigmine capsules in patients with traumatic brain injury. Brain Inj. 2009 Feb; 23(2):123-32.
Score: 0.243
-
Wortzel HS, Frey KL, Anderson CA, Arciniegas DB. Subtle neurological signs predict the severity of subacute cognitive and functional impairments after traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2009; 21(4):463-6.
Score: 0.241
-
Arciniegas DB, Silver JM. Pharmacotherapy of posttraumatic cognitive impairments. Behav Neurol. 2006; 17(1):25-42.
Score: 0.196
-
Arciniegas DB, Topkoff JL. Applications of the P50 evoked response to the evaluation of cognitive impairments after traumatic brain injury. Phys Med Rehabil Clin N Am. 2004 Feb; 15(1):177-203, viii.
Score: 0.172
-
Arciniegas DB. The cholinergic hypothesis of cognitive impairment caused by traumatic brain injury. Curr Psychiatry Rep. 2003 Oct; 5(5):391-9.
Score: 0.168
-
Arciniegas D, Adler L, Topkoff J, Cawthra E, Filley CM, Reite M. Attention and memory dysfunction after traumatic brain injury: cholinergic mechanisms, sensory gating, and a hypothesis for further investigation. Brain Inj. 1999 Jan; 13(1):1-13.
Score: 0.121
-
McDonald BC, Flashman LA, Arciniegas DB, Ferguson RJ, Xing L, Harezlak J, Sprehn GC, Hammond FM, Maerlender AC, Kruck CL, Gillock KL, Frey K, Wall RN, Saykin AJ, McAllister TW. Methylphenidate and Memory and Attention Adaptation Training for Persistent Cognitive Symptoms after Traumatic Brain Injury: A Randomized, Placebo-Controlled Trial. Neuropsychopharmacology. 2017 Aug; 42(9):1766-1775.
Score: 0.104
-
Kozora E, Filley CM, Zhang L, Brown MS, Miller DE, Arciniegas DB, Pelzman JL, West SG. Immune function and brain abnormalities in patients with systemic lupus erythematosus without overt neuropsychiatric manifestations. Lupus. 2012 Apr; 21(4):402-11.
Score: 0.074
-
Arciniegas DB. Clinical electrophysiologic assessments and mild traumatic brain injury: state-of-the-science and implications for clinical practice. Int J Psychophysiol. 2011 Oct; 82(1):41-52.
Score: 0.070
-
Kenfield MC, Arciniegas DB, Anderson CA, Howard KL, Filley CM. When cognitive evaluation does not disclose a neurologic disorder: experience of a university behavioral neurology clinic. Cogn Behav Neurol. 2010 Jun; 23(2):112-8.
Score: 0.067
-
Kozora E, Arciniegas DB, Filley CM, West SG, Brown M, Miller D, Grimm A, Devore MD, Wingrove C, Zhang L. Cognitive and neurologic status in patients with systemic lupus erythematosus without major neuropsychiatric syndromes. Arthritis Rheum. 2008 Nov 15; 59(11):1639-46.
Score: 0.060
-
Kozora E, Arciniegas DB, Zhang L, West S. Neuropsychological patterns in systemic lupus erythematosus patients with depression. Arthritis Res Ther. 2007; 9(3):R48.
Score: 0.053
-
Silver JM, Koumaras B, Chen M, Mirski D, Potkin SG, Reyes P, Warden D, Harvey PD, Arciniegas D, Katz DI, Gunay I. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology. 2006 Sep 12; 67(5):748-55.
Score: 0.051
-
Kozora E, Arciniegas DB, Filley CM, Ellison MC, West SG, Brown MS, Simon JH. Cognition, MRS neurometabolites, and MRI volumetrics in non-neuropsychiatric systemic lupus erythematosus: preliminary data. Cogn Behav Neurol. 2005 Sep; 18(3):159-62.
Score: 0.048
-
Arciniegas DB, Frey KL, Anderson CA, Brousseau KM, Harris SN. Amantadine for neurobehavioural deficits following delayed post-hypoxic encephalopathy. Brain Inj. 2004 Dec; 18(12):1309-18.
Score: 0.045
-
Arciniegas DB, Anderson CA. Viral encephalitis: neuropsychiatric and neurobehavioral aspects. Curr Psychiatry Rep. 2004 Oct; 6(5):372-9.
Score: 0.045
-
Ho PM, Arciniegas DB, Grigsby J, McCarthy M, McDonald GO, Moritz TE, Shroyer AL, Sethi GK, Henderson WG, London MJ, VillaNueva CB, Grover FL, Hammermeister KE. Predictors of cognitive decline following coronary artery bypass graft surgery. Ann Thorac Surg. 2004 Feb; 77(2):597-603; discussion 603.
Score: 0.043
-
Arciniegas D, Rojas DC, Teale P, Sheeder J, Sandberg E, Reite M. The thalamus and the schizophrenia phenotype: failure to replicate reduced volume. Biol Psychiatry. 1999 May 15; 45(10):1329-35.
Score: 0.031
-
Kozora E, Arciniegas DB, Duggan E, West S, Brown MS, Filley CM. White matter abnormalities and working memory impairment in systemic lupus erythematosus. Cogn Behav Neurol. 2013 Jun; 26(2):63-72.
Score: 0.020
-
Kozora E, West SG, Maier SF, Filley CM, Arciniegas DB, Brown M, Miller D, Grimm A, Zhang L. Antibodies against N-methyl-D-aspartate receptors in patients with systemic lupus erythematosus without major neuropsychiatric syndromes. J Neurol Sci. 2010 Aug 15; 295(1-2):87-91.
Score: 0.017
-
Filley CM, Kozora E, Brown MS, Miller DE, West SG, Arciniegas DB, Grimm A, Zhang L. White matter microstructure and cognition in non-neuropsychiatric systemic lupus erythematosus. Cogn Behav Neurol. 2009 Mar; 22(1):38-44.
Score: 0.015
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|